The FDA has approved Stoboclo (denosumab-bmwo), a biosimilar to Prolia (denosumab), and Osenvelt (denosumab-bmwo), a biosimilar to Xgeva (denosumab).

For patients with inflammatory bowel disease (IBD), risk factors associated with Clostridioides difficile infection (CDI) include recent diagnosis, corticosteroid usage, and hospitalization.

Sexual satisfaction is negatively impacted by living with Sjögren disease and is strongly correlated with depressive symptoms.

The Food and Drug Administration (FDA) has accepted the supplemental Biologics License Application (sBLA) for obinutuzumab (Gazyva®) for the treatment of lupus nephritis.

Gastrointestinal complications from alcohol are increasing among adolescents and young adults, according to a research letter.

Long-term nonsteroidal anti-inflammatory drug (NSAID) use is associated with reduced dementia risk, according to a study.

The risks for both bacterial and viral infections appear to be increased among children with Kawasaki disease.

Overactive bladder (OAB) is associated with arthritis, with a positive association seen after adjustment for all covariates.

Janus kinase inhibitor cycling may be more effective than switching to bDMARDs among patients with RA who had an inadequate response to initial JAK inhibitor therapy.

For patients with systemic lupus erythematosus (SLE) and pericarditis, recurrence of pericarditis occurs in more than 20% of patients and associated factors include younger age, prednisone treatment, ...

Engaging in physical activity seems to be beneficial to the mental health of women with chronic pelvic pain disorders (CPPD).

Relapse is common among patients with systemic polyarteritis nodosa, with mycophenolate performing similarly to cyclophosphamide.